Arvind Sonik, MD

• Department of Diagnostic Imaging
• UC Davis Medical Center
• Sacramento, California

The value of histological grade in breast cancer: experience from a large study with long-term follow-up depression nutrition purchase cheap anafranil on-line. Predominance of the basal type and Her-2/neu type in brain metastasis from breast cancer depression help groups cheap anafranil 25 mg. Neurotropin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis depression symptoms back pain order anafranil with visa. Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis depression screening definition cheap anafranil 10 mg visa. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma anxiety and nausea purchase anafranil once a day. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: A morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. The median survival of patients with multiple metastases in these series was approximately 3­4 months with treatment. The number of cerebral metastases is a significant prognostic factor, with better prognosis seen in single or oligometastatic disease (two to three cerebral metastases). Usually melanoma units will develop clinical pathways for patients depending on their prognosis, which is based on their presenting characteristics. The good news for patients is that all of these techniques are constantly and rapidly improving in terms of increasing survival and quality of life, with ever-decreasing toxicity from treatment. Patients are also being imaged earlier in their disease journey, even when asymptomatic. Practice can differ around the globe, usually because of historical factors and therapy availability. For example, different departments can have different ways of triaging patients to different treatments. Inappropriate to Use Data from Other Histologies Much progress has been based on well-conducted clinical trials. The longest disease-free interval from treatment of primary to first relapse in brain, which was the first presentation of metastatic disease, is 38 years in the Melanoma Institute of Australia, which has the largest and longest database of melanoma patients in the world. These are arranged on either side of the head, parallel to each other, irradiating toward the midline, in what is known as a pair of parallel opposed fields. The rationale is to treat microscopic disease at the site of initial metastasis, and elsewhere in the brain, to maintain long-term intracerebral control. Proponents say that radiotherapy to prevent or delay neurologic decline is worthwhile palliation. A complicating factor is that there exists an anecdotal impression among some clinicians that melanoma is radioresistant although there is no level 1 clinical evidence for this. An interim analysis will take place 1 year after half the patients have been accrued, due early 2014. Application of a Flawed Trial in All Histologies to this Scenario other challenges have involved new data from radiotherapy and new systemic therapy advances. The Chang trial studied patients with cerebral metastases from cancers of all histologies but mainly lung and breast. There were many other flaws with the trial, as pointed out in the ensuing correspondence (Thompson et al. Radiotherapy Techniques That Spare the Hippocampus Another radiotherapy challenge has come from improved radiotherapy techniques. Melanoma does have a different pattern of metastases from other solid tumors, for example, a comparatively high rate of small bowel metastases. New Targeted Systemic Therapies Another challenge has come from systemic therapies. Combinations of targeted drugs can give even longer progression-free survival with fewer side effects (Flaherty et al. Radiation Interactions A further concern for radiation oncologists is the possibility of radiation interactions with these new drugs. In other words, radiation oncologists will need to improve in their own skills and to engage translational scientists and other multidisciplinary partners such as medical and surgical oncologists in prospective trials that yield high-quality evidence if they want to make sure melanoma patients get the best radiotherapy and that radiotherapy remains a viable treatment option in melanoma. However, the lack of level 1 evidence has meant that this question cannot be definitely answered. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. The role of radiation therapy in the management of metastatic melanoma in the brain. Whole-brain radiation increases risk for cognitive decline in patients with brain metastases. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. Determinants of survival in patients with brain metastases from cutaneous melanoma. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Although there have been many improvements in the diagnosis, excision, and treatment of primary melanomas, the lethality of these tumors stems from their aggressive metastasis to secondary sites such as brain, bone, and lung (Postovit et al. Melanoma progression and metastasis are regulated both by intrinsic, tumor cell-autonomous factors, and by extrinsic factors in the tumor microenvironment (Huang et al. Intrinsic factors include mutations that affect tumor suppressor mechanisms, growth factor receptors, and growth factor production in transformed cells. It seems likely that improved melanoma therapy will require better understanding of both intrinsic and extrinsic mechanisms of tumor progression. Tumor vascularization is one of the most widely recognized stromal influences on the progression of melanomas and other types of tumors. Accordingly, tumor blood vessels have become attractive targets for cancer therapy. Although most therapeutic efforts have been focused on the vascular endothelium (You and McDonald, 2008; Kim et al. Similar to other types of microvessels, tumor blood vessels are composed of three main elements: pericytes, endothelial cells, and the vascular basal lamina (basement membrane) (Armulik et al. These components are highly interactive and communicate extensively with each other to determine vessel development, maturation, and function (Kalluri, 2003). Thus, uncoupling pericyteendothelial-basal lamina interaction at any level may have the potential to disrupt tumor vascularization. As part of our effort to understand the respective contributions of pericytes, endothelial cells, and the basal lamina to vascular morphogenesis and function, we have used a model of B16F10 melanoma microinjection into the mouse brain. By using mice with genetic modifications that affect different elements of tumor microvessels, we have attempted to identify molecular aspects of vascular interaction that may be susceptible to therapeutic attack. In addition, tumors in this location may provide useful information regarding the behavior of metastatic melanomas in the brain. Pericytes ensheath the outer surfaces of endothelial cells that form the vascular lumen, promoting vascular development and maturation via their interactions with the endothelial cells (Armulik et al. The basal lamina is also contacted by astrocytic endfeet (orange) and neuronal processes (purple). Unlike endothelial cells in peripheral vessels, cerebral endothelial cells form a continuous luminal surface with no fenestrations. The integrity of the blood­brain barrier depends on a network of tight junctions (arrows) between the cerebral endothelial cells, creating a rate-limiting barrier to diffusion of solutes. Most pericytes in tumor vessels from wild-type mice were positive for both pericyte markers (B). In extending our studies to the role of pericytes in melanoma vascularization in the brain, we have benefited from the fact that the density of pericyte ensheathment of endothelial cells is higher in the central nervous system (CnS) than in other organs (Bergers and Song, 2005). When we microinjected B16F10 melanoma cells (C57Bl/6 origin) into the corpus callosum of wild-type and nG2-null C57Bl/6 mice, we found that tumor progression was reduced roughly threefold by the ablation of nG2 (Huang et al. Because B16F10 cells do not express nG2, the observed difference in tumor growth in the two mouse lines must be due to the presence versus absence of nG2 in the respective host microenvironments. Pericytes, macrophages, and oligodendrocyte progenitors are the host cell populations that normally express nG2 in the brain. Based on our previous finding of pericyte deficits in the vasculature of the nG2-null mouse (ozerdem and Stallcup, 2004), we initially focused our attention on the pericyte/vascular compartment of the melanoma stroma. Comparison of microvessels in the tumors from wild-type versus nG2-null mice revealed that pericyte recruitment was unaffected by nG2 ablation, but that pericyte ensheathment of endothelial cells was reduced twofold in the absence of nG2 (Huang et al. This change in pericyte­endothelial cell interaction resulted in developmental deficits in both vascular cell populations, as well as in the basal lamina. From a functional standpoint, tumor vessel patency was reduced twofold in the nG2-null mouse, whereas vessel leakiness was increased by a factor of 4 (Huang et al. These deficits in vessel function led to a 20-fold increase in intratumoral hypoxia in the nG2-null mouse. We have observed a very similar spectrum of vascular deficits in mammary tumors growing in nG2-null mice (Gibby et al. These findings demonstrate the importance of nG2 in pericyte biology, and emphasize the extremely tight nature of the interactions that exist between pericytes, endothelial cells, and the basal lamina. In addition, these results suggest nG2 as a possible candidate for targeting pericyte function as a means of disrupting tumor vascularization. Structural proteins, including collagens, laminins, and fibronectin, provide tensile strength to maintain basal lamina morphology. Proteoglycans provide hydration, as well as a means of sequestering key growth factors, cytokines, and chemokines needed for regulating vascular cell populations (Coussens and Werb, 2002; Kalluri, 2003). In our study of B16F10 tumor growth in nG2-null mice, we noted the important indirect effect of altered pericyte biology on assembly of the vascular basal lamina. Thus, changes in the nature of the vascular basal lamina are responsible for changes in pericytes and endothelial cells and in the functional properties of vessels. It is therefore understandable that the majority of studies in vascular biology have focused on vascular endothelial cells. In our studies on B16F10 tumors in the brain, we have observed interesting changes in vascular endothelial cells resulting from alterations in the basal lamina. In the absence of a robust basal lamina, these signaling processes are weakened, leading to the observed negative effects on the properties of endothelial cells. These experimental results further emphasize the importance of basal lamina assembly for normal endothelial cell function. This approach has been very successful from a structural standpoint, because the three microvascular components occupy distinct spatial domains that can be clearly defined. By genetic ablation of the nG2 proteoglycan, we hoped to interfere with pericyte function as a means of determining pericyte-specific contributions to the development of tumor microvessels (Huang et al. This approach proved to be shortsighted in light of our current understanding that nG2 is important for pericyte interaction with endothelial cells. This interaction occurs, at least in part, via nG2 activation of b1 integrin signaling on the endothelial cell surface (Fukushi et al. In the wake of reduced pericyte­endothelial cell interaction, pericyte maturation is impaired (Huang et al. In addition, because deposition of the basal lamina requires the cooperative efforts of pericytes and endothelial cells, assembly of this critical structure is retarded by diminished pericyte­endothelial cell interaction. From a functional standpoint, these cumulative deficiencies are associated with reduced numbers of patent vessels and with increased vessel leakiness. This poor vascular function correlates with increased levels of intratumoral hypoxia and retarded B16F10 tumor progression in the brains of nG2-null mice (Huang et al. A very similar set of phenomena is observed for mammary tumors growing in nG2-null mice (Gibby et al. This strategy was partially successful, in that basal lamina assembly in melanoma vessels was reduced without an apparent effect on pericyte ensheathment of endothelial cells (You et al. These structural and developmental changes in tumor vessels were accompanied by decreased vessel patency, increased vessel leakiness, increased intratumoral hypoxia, and retarded tumor progression (You et al. Thus, because of the extensive crosstalk between microvessel components, defects in the basal lamina resulted in collateral damage in the pericyte and endothelial cell compartments. In the absence of a robust basal lamina, b1-integrin expression and signaling are reduced in endothelial cells. In retrospect, it seems obvious that changes in vessel functionality should be of primary importance in assessing the effects of tumor or stromal cell mutations on the tumor vasculature and tumor progression. Yet numerous studies continue to focus on determining the effects of tumor or stromal cell mutations on vascular density, giving little consideration to how well vessels are functioning. However, the intimate involvement of pericytes, endothelial cells, and the basal lamina in achieving optimal vessel function suggests that antiangiogenic therapy might benefit from targeting all three components of the microvasculature.

The precipitation causes the formation of non-resorbable particles that became and act as foreign bodies for the organism mood disorder questionnaire spanish 25 mg anafranil mastercard. We suspect that the chemical formation of these precipitates is part of the cancer mechanism depression symptoms violence generic 50 mg anafranil amex. These elements probably come from the extracellular matrix anxiety 30002 anafranil 75 mg with visa, released by the dead cells depression vegetative symptoms definition generic 50 mg anafranil with visa, but there is also the possibility of a precipitation inside the cell itself mood disorder 29696 50 mg anafranil free shipping. In this case, after the cell death those precipitates are released into the tissue, as ghosts of a cell. Clinical Cases 45 In order to understand the spherular calcification we consider another pathology where there is the precipitation of iron for the genetic absence of a protein: siderosis. The images show submicronic and nanosized precipitates of iron in a cytoplasmic area. The absence of suitable metabolism for iron causes its accumulation and, when the saturation concentration is reached, it precipitates according to the laws of chemistry. These precipitates are not biodegradable, so they are just foreign bodies to the tissue. The formation of similar precipitates in globular form in a cancerous tissue can make us presume that in that case a saturation concentration is also reached and that the environmental pollution identified has disturbed the metabolism. Can the nanosized formation of those spherules be due to the presence of nanosized foreign bodies? Broca first described this tumor in 1868, whereas the term "ameloblastoma" was coined by Churchill in 1933 [13]. Ameloblastoma is notorious for its slow growth, histologically benign appearance and high incidence (50-72%) of local recurrence. Its etiology is also controversial because it is benign but over time can show malignant features. Typically, it occurs in intraosseous tooth-bearing areas of the jaws, especially in the molar region, and on X-ray appears as a cystic, multilocular or unilocular, lesion. In the 1960s, several authors investigated the possibility of a viral role (Papova family) in the origin of ameloblastoma [13­16]. As negative controls in this study we used the specimens of both the maxillary and mandibular molar regions of six patients, who gave their consent to have a biopsy performed during the extraction of their upper or lower third molar. The results indicated that while there was no presence of foreign bodies in all the negative controls analyzed in each ameloblastoma sample, exogenous micro- and nanoparticles of different size and composition were found Table 4. First of all because we identified among them nanoparticles (analyses 20, 12, 13) and submicronic ones ranging from 0. The calcium phosphate with copper of analysis 33 could also be a component of dental cement, while the calcium phosphate of analysis 21 is the calcification reaction to the presence of foreign bodies. There are debris related to an amalgam drilling probably occasioned by a removal (8,32,33). Titanium of analyses 22 and 43 could be related to elastic burs or endodontic tools. So, out of the 44 chemical compositions identified, only 10 could not have a dental material origin. It is also likely that analyses 12, 13 and 14, with lead and zinc, are related to something exogenous. The presence of these debris is almost certainly related to the release of submicronic and nanosized debris due to dentistry malpractice. The dentist might have neglected to use due protections such as, for instance, a dental dam. Clinical Cases 49 bridges and a crown and, after that, she developed burning-mouth syndrome, a frustrating condition often described as a scalding sensation in the tongue, lips, palate or throughout the mouth. A simple dabbing of the gum with an adhesive carbon stub revealed the presence of debris related to a metallic prostheses drilling. In that case, we suggested repeated washings of the mouth with relatively hot water. Vesicles were formed that broke, releasing the debris trapped as a consequence of the use of the high-speed handpiece. The debris of the prostheses and of the burs scattered in all directions in the mouth. The ameloblastoma findings show a relationship between the pathology and the physical presence of nanoparticles trapped by the tissue. It is mandatory to emphasize that the Italian soldiers went to the former-Yugoslavia territories when the bombing by the AmericanBritish alliance was already over, but during their activity they patrolled warpolluted areas (in some cases contaminated by depleted uranium bombs) and also lived in partially-destroyed buildings and in bombed factories. A camp-hospital was located inside the area of the bombed Zastava factory, a car, firearm and artillery manufacturer based in the city of Kragujevac in central Serbia. So, medical doctors, caregivers, patients and soldiers spent their whole days in contact with the pollution generated by bombs and targets, in this case a huge quantity of metallic pollutants. Much of the particles produced floated in the air, but part of them penetrated through the air-conditioning system, thus entering the rooms. We received samples taken from the soldiers, young men who left Italy in healthy condition, were sent on peacekeeping missions, and, after a few months, returned ill. Some had developed blood disorders, others leukemia and, in some cases, they died in a short time. After some years, some of the subjects suffering from blood disorders showed a myeloma. Some time later we also received samples of soldiers affected by lymphoma, and the same occurred with samples of civilians coming from Sarajevo (Bosnia & Herzegovina). We thought that there was a sort of homogeneity of exposure among the 24 cases of civilians exposed to the "war pollution," but it was not so, since, during the Balkan war, there were many migrations among the population, so they were subjected to a variety of exposures. Some of the war cases will be discussed in Chapter 7, where similar situations occurred at Quirra, a small village close to a firing range in Sardinia (Italy). Also in that location, cases of lymphoma or other forms of cancer were registered both among the population and soldiers working in the firing range. Among the cases we had the opportunity to analyze, was the case of an 18-year-old girl who was admitted to a hospital with a diagnosis of leukemia. The toxicity of silver has been known since ancient times because of argyria, a condition due to chronic ingestion or inhalation of silver dust or compounds of that metal. The most visible symptom is the bluish color of the skin in more or less extended regions of the body, the mucous membranes or the conjunctiva. Today nanosilver is the main component of many nanoproducts available on the market, from wound bandages to sports garments, from filters for water to toothpastes, from spermicide vaginal foam to pesticides, etc. He ordered the exhumation of a shepherd who died of leukemia and gave us a tibia to check if inside the medullary cavity where once was the bone marrow foreign bodies were present. The presence of calcium and phosphorus were due to the bone surrounding the spherical debris. His profession of shepherd was performed in an environment free from industrial pollution. With his flock he stayed in a wild environment but where experimental war activities were also carried out. The most logical explanation for the strange chemical compositions of the debris found inside the bone is that he and his animals were exposed to war pollution. It is composed of iron, copper, zinc, phosphorus, magnesium, aluminium, silicon, sulphur and titanium (b). However, as a matter of fact, malformation cases are increasing in polluted areas. The approach to malformed babies was due to an elementary problem of "reference samples. Although it is obvious that biological tissues contain mainly just carbon, oxygen, hydrogen and nitrogen besides other elements less represented in the tissues and not, for instance, spherules of stainless steel, it is necessary to demonstrate that the particles we find in the progress of our analyses do not belong in non-exposed living bodies. As just mentioned, cells, tissues and organs contain carbon, oxygen, nitrogen, hydrogen, but the living matter also contains Na, Mg, P, Fe, K, Cu, Zn plus a few other elements in trace, but those are not detectable with our technique. In any case, none of those elements is present either singularly or in combination as particles in a non-contaminated organism. But, in the case of nanopathologies, we thought that the best controls should be the biological tissues that were never exposed to environmental pollution. So, since we assumed that fetuses are not in communication with the external environment or, at least, they are effectively protected, the most logical choice Clinical Cases 55 seemed to be tissues from miscarried or voluntarily aborted fetuses. According to what we thought, those tissues should be free from exogenous pollutants and could ideally be used for reference. The analyses of the internal organs of fetuses showed us that their tissues were actually free from foreign bodies, but in one case we detected the presence of submicronic solid pollutants. We discovered this because the technician who prepared our samples also included a case of a malformed fetus. The mother who had conceived the baby lived in a highly industrialized, heavily polluted area. The presence of those particles demonstrated that the placental barrier was not efficient enough to stop the submicronic and nanosized particles, which could reach the fetus, and which lead us to suspect that they could negatively influence its development. A specific study on eight malformed babies born in an industrialized area of Sicily (South of Italy) where oil refineries are located was carried out. The malformed babies were affected by neural tube defects such as spina bifida, and eight controls with no overt malformation syndromes whose mothers were authorized for abortion between 21 and 23 weeks of gestation were also checked. The study demonstrated that in the internal organs (liver and kidney) of the fetuses metallic particles were present in direct relation to the environmental pollution released by the refinery effluents and, in general, related to the combustive processes involved in that kind of industrial activity [23]. The number of total particles was significantly higher in the neuraltube-defect group, while the mean size and number of the particles detected in kidney and liver tissues did not differ between the groups. In neural-tube defects we noticed that the number of iron, silicon and magnesium particles was significantly higher (P < 0. It is possible that the presence of a foreign pollution at an early stage of development can trigger a cascade of events multifactorially or genetically mediated. Further investigations are necessary to elucidate the relationship between central nervous system malformations and pollution at a nanoscale stage. We found also very unusual particles; for instance, crystals of bismuth, chromium, aluminium and copper. Particularly the form they were found in, these elements are not biocompatible/biodegradable and are chemically toxic. Therefore, the possibility that neural-tube-defects fetuses were exposed to a kind of environmental pollution aggressive to the central-nervous system development is substantial. Particles similar in size, morphology and chemical composition were identified also in the air filters of the atmospheric control units of the local agency for the environmental protection used during the previous winter months. So, while the mother is somehow protected, the growing embryo accumulates exogenous foreign bodies that can interfere with cell duplication. In that fetus, we found debris containing the following elements: iron, silicon, chromium, zinc, aluminium, magnesium, nickel, copper, titanium, lead, barium and tin. If small debris, transported by the blood, reach the embryo they can interfere with its normal development, causing deviation from normal growth. If foreign metallic particles, in contact or internalized in the embryo, are found, they can corrode and release ions that can interfere negatively with the cell metabolism and the normal fetal evolution. A rather uncommon disease, even if it seems to grow and occur more frequently than in the past, and there are no suitable drugs available to eliminate the disease, but only pharmaceutics to silence the symptoms. It is a medical condition caused by proteins called cryoglobulins, abnormal proteins, mostly immunoglobulins, present in the blood that have the unusual, reversible, property of precipitating from the serum specimen at low temperatures. After cooling the serum at -4°C, they precipitate, forming a white substrate at the bottom of the vial and then they can be dissolved again into the serum upon rewarming at 37°C [24]. Brouet [25] classifies cryoglobulinemia according to cryoglobulin composition: Type I is the result of a monoclonal immunoglobulin, often immunoglobulin M (IgM) or, more rarely, immunoglobulin G (IgG), immunoglobulin A (IgA), or light chains. Clinical Cases 57 these factors form complexes with the crystallizable portion of polyclonal IgG. The symptoms of the disease include hyperviscosity of the blood, arterial and venous thrombosis, acrocyanosis, retinal hemorrhage, severe Raynaud phenomenon [26] with digital ulceration, livedo reticularis [27,28], purpura [29], membranoproliferative glomerulonefritis and multiple myeloma [30]. In this hypothesis, the autoimmune symptoms could be induced by the proteinous coating of these foreign bodies, which adhering to the debris can change their three-dimensional conformation and cannot be recognized by the body. The results indicate that all samples had the systematic presence of micro- and nanometric-sized (0. In a 20-microl sample of cryoglobulins we found up to 28 debris, ranging from some hundredths of nanometers to 7 micron: the latter the same size as a red cell. Siliconbased materials were composed mainly of silicon and aluminium along with other elements such as calcium, iron, sodium, magnesium, etc. Other ceramic debris found was composed of aluminium oxide, zirconium oxide, calcium oxide and barium sulfate. Metals were mostly represented by iron-based compounds also containing zinc and manganese. Many particles of stainless steel (iron, chromium and nickel), iron and titanium were identified. Inside the cryoglobulins we also found particles with complex compositions such as C-Si-Ca-O-Pb-P-Na-C; Fe-C-Cr-O-S-Cl-Br-Si-P-Na; C-Cu-Cl-Na-Al-O-P-Ca-S-Fe-K;C-O-Sb-Cl-Al-P-S-Na-Ti;C-Sn-O-ClPb-P-Si-Al; C-Si-Al-O-S-Ca-P-K-Mg-Cl-Fe-Na-Ti-Zn; W-C-Fe-S-Cr; C-O-Fe-Cl-Cr-Si-Na-S-P-Ca-V. The most represented elements were: Si 22%, Al 19%, Fe 18%, Ca 13%, Mg 12%, Ti 4% and Cr 2%, and the rest was composed of Mn, Zn, Cu, Ba, Pb, Zr,V, W, Sb and Au. Silicates and iron-based debris were found embedded both in the globulins and in the kidney biopsies. The ceramic debris (silicon or aluminium compounds) can be from ceramic factories. In fact, around Modena, the Italian town where the study was carried out, there are more than 200 ceramic factories that pollute the area. As in many other circumstances, most of the compositions we found in the particles are not mentioned in any handbook of materials, since they would not have any practical application. The odd element combinations Clinical Cases 59 are often due to a chance meeting of chemicals released by combustions such as, for instance, the ones occurring in waste incinerators, in which what is burned has a chemistry that rapidly varies over time. The chemical coincidence of the debris found in the cryoglobulins and in the biopsies of the kidneys proves that the particles, be they inhaled or ingested, were, at least partially, trapped in the plasma proteins while others escaped and were captured by the liver and the kidneys. In one case, we verified that the gold particles identified in the cryoglobulins and in the kidney biopsy could have come from a pharmacological therapy to treat arthritic pains with colloidal gold. When the contamination is deeply embedded in a tissue/ organ only surgery can eliminate it.

Buy anafranil 50 mg fast delivery. How to Deal With Job-Search Depression.

The patient was treated by systemic chemotherapy and head and neck radiotherapy mood disorders buy generic anafranil 10 mg online, and was reported to be alive (at the date of writing the article) on palliative treatment anxiety 1-10 scale order 50 mg anafranil fast delivery. We recently published a case report of a 54-year-old male patient depression test cyclothymia 25 mg anafranil sale, a Jewish white Israeli of North African descent (Kaidar-Person et al bipolar depression 5htp buy anafranil cheap. The patient received one cycle of induction chemotherapy (according to our department protocol) with cisplatin (100 mg/m2 bipolar depression 4 months anafranil 10 mg buy otc, day 1) and 5-fluorouracil (1000 mg/m2, days 1­5). The fifth day of 5-fluorouracil was omitted because of acute renal failure, which resolved with conservative treatment. Brain MrI excluded any additional brain lesions or direct tumor invasion to the brain. A history of nasal infection or otitis media was recognized in all six patients with brain abscess. Three of the patients with brain abscess had previous treatment with steroids for the symptomatic radiation necrosis. All patients were treated surgically by temporal lobectomy and excision of the necrotic tissue together with the abscess cavity. The authors recommended the surgical excision as the treatment of choice in this group of patients (Cheng et al. Serious late toxicities, such as brain necrosis, remain a concern demanding further improvement in radiotherapy technique and optimization of dose fractionation. A multidisciplinary team including medical oncology, neuro-oncology, neurosurgery, and radiation oncology experts should consider the appropriate treatment for nasopharyngeal brain metastasis. The extent and nature of systemic disease should be taken into consideration for treatment approach. Brain abscess formation in radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma. Intracranial metastases in patients with squamous cell carcinoma of the head and neck. Bacterial brain abscess in patients with nasopharyngeal carcinoma following radiotherapy: microbiology, clinical features and therapeutic outcomes. The incidence of invasion and metastasis of nasopharyngeal carcinoma at different anatomic sites in the skull base. Increased risk of nasopharyngeal carcinoma among males of French origin born in Maghreb (North Africa). Brain metastasis of nasopharyngeal carcinoma: a case report and literature review. Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature. Undifferentiated nasopharyngeal carcinoma with isolated central nervous system metastasis. Nasopharyngeal carcinoma with skull base invasion and hydrocephalus: a case report. Hospital admissions, although uncommon, are also increasing, as are admissions to critical care units. We also reference key evidence based international and national anaphylaxis guidelines and their updates. The widely used definition of anaphylaxis-"a serious allergic reaction that is rapid in onset and may cause death"-is accompanied by clinical criteria for diagnosis,3 which have been validated for use in clinical and research contexts (fig 1). Death occurs as often after respiratory arrest as it does after shock or cardiac arrest. The clinical features of anaphylaxis result from sudden release of histamine, tryptase, leucotrienes, prostaglandins, platelet activating factor, and many other inflammatory mediators into the systemic circulation. Typically, this occurs through an immune mechanism involving interaction between an allergen and allergen specific IgE bound to high affinity IgE receptors on mast cells and basophils. However, IgE independent immune mechanisms and direct degranulation of mast cells are sometimes responsible, and other episodes, especially in adults, are idiopathic (box 1). Some develop iatrogenic anaphylaxis after administration of a diagnostic or therapeutic agent. Others present to the emergency department after experiencing anaphylaxis in the community; in such patients, the duration of symptoms and signs varies from minutes to hours, and treatment with adrenaline (epinephrine), oxygen, intravenous fluids, an H1 antihistamine, a glucocorticoid, or other drug might have already been started. In addition, many patients present to their doctor with a history of anaphylaxis that occurred weeks, months, or even years earlier, which may or may not have been appropriately investigated or followed up. Regardless of the scenario, the clinical diagnosis of anaphylaxis is based on the history of the acute episode. Clinical presentation Anaphylaxis is characterised by symptom onset within minutes to a few hours after exposure to a food, drug, insect sting, or other trigger (box 1). Two or more body organ systems (cutaneous, respiratory, gastrointestinal, cardiovascular, or central nervous system) are usually affected (box 3; fig 1). Pregnant women can experience intense itching of the genitalia, abdominal cramps, back pain, signs of fetal distress, and preterm labour. Upper and lower respiratory tract symptoms and signs occur in up to 70% of those experiencing anaphylaxis and cardiovascular symptoms and signs in about 45%. Gastrointestinal symptoms occur in about 45% and central nervous system symptoms and signs in about 15%. The patterns of target organ involvement vary between patients, and in the same patient from one episode to another (fig 1). Anaphylaxis can range in severity from transient and unrecognised or undiagnosed episodes, to respiratory arrest, shock, cardiac arrest, and death within minutes. Sudden onset of an illness (minutes to several hours), with involvement of skin, mucosal tissue, or both (for example, generalised hives, itch, or flush or swollen lips, tongue, or uvula) And at least one of the following: Sudden respiratory symptoms and signs (for example, shortness of breath, wheeze, cough, stridor, hypoxaemia) Or Sudden reduced blood pressure or symptoms of end organ dysfunction (for example, hypotonia (collapse), incontinence) 2. Two or more of the following that occur suddenly after exposure to a likely allergen or other trigger* for that patient (minutes to several hours): Sudden skin or mucosal symptoms and signs (for example, generalised hives, itch, or flush or swollen lips, tongue, or uvula) Or Sudden respiratory symptoms and signs (for example, shortness of breath, wheeze, cough, stridor, hypoxaemia) Sudden reduced blood pressure or symptoms of end organ dysfunction (for example, hypotonia (collapse), incontinence) Sudden gastrointestinal symptoms (for example, crampy abdominal pain, vomiting) 3. Normal heart rate ranges from 80 to 140 beats/min at age 1-2 years; from 80 to 120 beats/min at age 3 years; and from 70 to 115 beats/min after age 3 years. These diagnostic criteria were developed by a National Institutes of Health sponsored international consensus group in 2004-06 to facilitate prompt recognition of anaphylaxis1 3 2 impossible to predict the rate of progression, the ultimate severity, or the likelihood of death. Serial measurements are reported to improve test specificity and are ideally obtained 15-180 minutes after symptom onset, one to two hours later, and after resolution of the episode. A raised baseline value suggests the diagnosis of mastocytosis rather than anaphylaxis. Measurement of mast cell tryptase concentration-the most widely used laboratory test-is not universally available, takes hours to perform, is not available on an emergency basis, and is not helpful for confirming the clinical diagnosis of anaphylaxis in the initial minutes or hours after symptom onset. Treatment must therefore not be delayed to obtain a blood sample for tryptase measurement. Total tryptase concentrations measured in serum during an anaphylaxis episode can, however, sometimes be helpful later to confirm the diagnosis, especially in patients with drug or insect sting induced anaphylaxis and those with hypotension. Consider the possibility of an uncommon or novel trigger (such as galactose -1,3-galactose, the carbohydrate moiety in red meat; saliva injected by biting insects; or topically applied allergens such as chlorhexidine) or a concurrent diagnosis of mastocytosis. In addition, those taking adrenergic blockers may not respond optimally to adrenaline treatment and may need glucagon, a polypeptide with non-catecholamine dependent inotropic and chronotropic cardiac effects, atropine for persistent bradycardia, or ipratropium for persistent bronchospasm. However, in many immunisation clinics, infusion clinics, and allergen immunotherapy clinics, nurses are preauthorised to do this. A comprehensive list is provided to aid in prompt recognition and to indicate the possibility of rapid progression to multiorgan system involvement. Skin, subcutaneous tissue, and mucosa Generalised flushing, itching, urticaria (hives), angio-oedema, morbilliform rash, pilor erection Periorbital itching, erythema, oedema, conjunctival erythema, tearing Itching or swelling (or both) of lips, tongue, palate, uvula, external auditory canals Itching of the genitalia, palms, soles Respiratory · Nasal itching, congestion, rhinorrhoea, sneezing · Throat itching, tightness, dysphonia, hoarseness, dry staccato cough, stridor · Lower airways: cough, increased respiratory rate, shortness of breath, chest tightness, wheezing · Cyanosis · Respiratory arrest Gastrointestinal · Abdominal pain, dysphagia, nausea, vomiting (stringy mucus), diarrhoea Cardiovascular system · Chest pain (myocardial ischaemia)* · Tachycardia, bradycardia (less common), other dysrhythmias, palpitations · Hypotension, feeling faint, incontinence, shock · Cardiac arrest Central nervous system · Feeling of impending doom, uneasiness, headache (pre-adrenaline), altered mental status or confusion owing to hypoxia, dizziness or tunnel vision owing to hypotension, loss of consciousness Other · Metallic taste in the mouth *This can occur in patients with coronary artery disease and (owing to vasospasm) in those with normal coronary arteries. When the initial injection is given promptly after symptoms are recognised, patients seldom require more than two or three injections. Compared with the intravenous route, the intramuscular route has the advantages of rapid initial access and a considerably wider margin of safety. The recommendation for intramuscular injection of adrenaline is based on consistent clinical evidence supporting its use, observational studies, and objective measurements of adrenaline absorption in randomised controlled clinical pharmacology studies in people not experiencing anaphylaxis at the time of study. In addition, all doctors play a role in optimal management of asthma, cardiovascular disease, and other comorbidities that contribute to the severity of anaphylaxis and death. Allergy and immunology specialists play an important role in ascertaining the trigger(s) of an anaphylaxis episode, providing written information about avoidance of specific triggers, and, where relevant, preventing anaphylaxis by desensitisation to a drug or initiating and monitoring stinging insect venom immunotherapy. The transient anxiety, pallor, palpitations, and tremor experienced after administration of a relatively low first aid dose of exogenous adrenaline are caused by its intrinsic pharmacological effects. These symptoms are uncommon after an intramuscular injection of the correct adrenaline dose. They are most commonly reported after an intravenous bolus dose, overly rapid intravenous infusion, or intravenous infusion of a concentrated adrenaline solution 1 mg/mL (1:1000) instead of a solution that is appropriately diluted for intravenous use. Hypoxia, acidosis, and the direct effects of the inflammatory mediators released during anaphylaxis can contribute to cardiovascular complications. Tell patients that they have experienced a potentially life threatening medical emergency. If possible, they should be discharged with an adrenaline autoinjector, or at a minimum, a prescription for one, and taught why, when, and how to inject adrenaline (box 5). In addition, patients should wear medical identification (bracelet or card) that states their diagnosis of anaphylaxis, its causes, and any relevant diseases or drugs. Appropriate investigation and follow-up after recovery from an episode may protect against recurrences. Avoid testing with large numbers of allergens because sensitisation to allergens is common even without a history of symptoms or signs after exposure to the specific allergen. Skin tests are optimally performed about four weeks after the acute episode, rather than immediately after, when test results may be falsely negative. Patients with a convincing history of anaphylaxis who have negative skin tests within a few weeks after an episode should be retested later. Patients with idiopathic anaphylaxis need additional tests to investigate any unusual or novel triggers and to rule out mastocytosis. They should be placed on their back (or in a semireclining position if dyspnoeic or vomiting) with their lower extremities elevated. At any time during the episode, when indicated, additional important steps include giving high flow supplemental oxygen and maintaining the airway, establishing intravenous access and administering high volumes of fluid, and initiating cardiopulmonary resuscitation with chest compressions before starting rescue breathing. Such specialists and their teams are trained, experienced, and equipped to provide skilled management of the airway and mechanical ventilation, and to manage shock by administering adrenaline or other vasopressors through an infusion pump. The absence of established dosing regimens for intravenous vasopressors necessitates frequent dose titrations based on continuous monitoring of vital signs, cardiac function, and oxygenation. Personalised written instructions about avoidance of confirmed relevant trigger(s) and safe alternatives should be provided for patients at risk, who should also be directed to reliable, up to date information resources. In healthcare settings, flag medical records with "anaphylaxis" and list relevant triggers. Long term avoidance of food triggers can be stressful because of the threat of hidden crossreactive or cross contaminating allergens. New immune modulation strategies to achieve clinical and immunological tolerance to implicated foods and prevent recurrences of food triggered anaphylaxis are within reach, as demonstrated in randomised controlled trials, although they are not yet recommended for clinical implementation because of high adverse event rates. As an example, patients at high risk of anaphylaxis from infusion of radiocontrast medium during diagnostic procedures, or those with frequent episodes of idiopathic anaphylaxis, are often treated prophylactically with an H1 antihistamine, glucocorticoid, or other drug. Most prophylactic regimens are based on clinical experience rather than on randomised controlled trials. Patients at risk for anaphylaxis in the community should be monitored regularly-for example, at yearly intervals- by their doctor. Such visits provide the opportunity for personalised education on how to prevent recurrences, recognise anaphylaxis symptoms, and self inject adrenaline correctly. An important aspect of follow-up is to help patients (and carers of at risk children) control asthma or other comorbid disease that potentially increase the risk of severe or fatal anaphylaxis episodes. If such an agent is not available, desensitisation to the implicated agent is indicated to induce temporary clinical tolerance for one uninterrupted course of treatment with that agent. Desensitisation to antimicrobials, antifungals, antivirals, chemotherapeutics, monoclonal antibodies, and other agents is carried out in specialised hospital units. This approach, which is based on high quality randomised controlled trials, should be initiated and monitored by an allergist. It leads to clinical and immunological tolerance, and in about 90% of adults and 98% of children, to longlasting protection against recurrence. Patients should not exercise alone and should carry an adrenaline autoinjector and a mobile phone. If an episode occurs despite preventive measures, treatment involves discontinuing exertion immediately on recognition of initial symptoms, calling for help, and self injecting adrenaline promptly. World Allergy Organization guidelines for the assessment and management of anaphylaxis. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patients. Algorithm for the diagnosis of anaphylaxis and its validation using populationbased data on emergency department visits for anaphylaxis in Florida. Strategies for living with the risk of anaphylaxis in adolescence: qualitative study of young people and their parents. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review.

In our department local anaesthesia and arterial puncture is obtained under ultrasound guidance as it has been reported to produce a superior analgesic effect [5] depression test from doctors generic anafranil 75 mg with mastercard. The peroneal artery demonstrated marked calcifications of the vessel wall anxiety 5-htp proven anafranil 10 mg, typical of Case 8 Below knee angioplasty: bare vs drug-eluting stents Expert comment 71 Decreased contrast media enhancement of a specific infrapopliteal arterial segment combined with decreased arterial flow should be considered as a radiological sign of flow-limiting atherosclerotic disease and treated appropriately depression questionnaire order anafranil 10 mg overnight delivery. A check angiogram after the deployment of the first stent demonstrated elastic recoil of the previously pre-dilated nearocclusion depression symptoms dizziness order generic anafranil on-line. The arterial segment between the two stents (circled area) was subsequently covered with a 2 depression checklist proven 75 mg anafranil. Post-procedural surgical care was advised with clinical follow-up of regular visits at one and six weeks, six and twelve months, and annually thereafter. The Rutherford­Becker classification at six and twelve months follow-up improved from 5 to 2 (moderate claudication). After three years clinical follow-up the patient is alive and has not suffered any major or minor amputation, and there are no signs of clinical relapse. Stenting is usually reserved as a bail-out option following suboptimal or complicated angioplasty [7,8]. Although this case was not technically challenging compared with other cases presenting with long occlusions, bifurcation lesions, or distal pedal disease, it was described because it summarizes the essence of percutaneous treatment and also includes some technical key points crucial for the achievement of long-term clinical success. Modern treatment protocols consider the endovascular approach as the treatment of choice in these cases [1]. Moreover, the patient was not fit for surgery and consequently percutaneous treatment was the only valid revascularization option. The second key point was the decision to perform direct stenting using sirolimuseluting stents in a long lesion (9cm). This decision was based on the exceptional reported outcomes of bail-out drug-eluting stenting in short lesions and the initial positive results obtained by direct stenting of long lesions in our department [8,11­14]. At one year follow-up: in-segment binary restenosis (by quantitative angiography), 22. Compared 66 patients treated with bare metal stents (Multi link Vision) with 74 patients treated with everolimus-eluting stents (Xience V©). On a 0­10 scale the patient rated his preprocedural health status as 4/10, while aftera a one-year follow-up his health status improved by four points (8/10). He also stated that he no longer experienced pain or lifestyle-limiting claudication after three years follow-up. However, these results refer to relatively short lesions, with the exception of results obtained recently by Katsanos et al. In such cases, alternatives such as the emerging drug-coated balloon technology should be considered. High temporal and spatial resolution 3D timeresolved contrast-enhanced magnetic resonance angiography of the hands and feet. Does ultrasound-guided lidocaine injection improve local anaesthesia before femoral artery catheterization? Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. Comparison of sirolimus-eluting vs bare-metal stents for the treatment of infrapopliteal obstructions. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. More specifically, the patient complained that her left leg felt cold and numb, with moderate motor and sensory loss evident. Native arterial thrombosis remains the main cause of the disease, accounting for 85% of cases, followed by embolism; less common causes include trauma and acute arterial dissection [3]. Post graft placement she underwent two endovascular procedures in order to deal with distal anastomosis stenotic lesions. Her medications included warfarin, isosorbide dinitrate (20mg twice daily), ranitidine (300mg twice daily), atorvastatin (80mg once daily), bisoprolol fumarate (5mg once daily), nicorandil (10mg twice daily), ramipril (5mg once daily), isosorbide mononitrate (60mg once daily), naproxen (500mg twice daily), aspirin (75mg once daily), calcium 600mg, colecalciferol 400 units chewable tablets (once daily), and mirtazapine (30mg once daily). A high-grade calcified stenosis of the proximal anterior tibial artery was also evident. In addition, (b) the left side femoropopliteal bypass graft was thrombosed and (c, d) there was filling of the above knee popliteal artery. More specifically, endovascular options include catheter-directed infusion of pharmacological thrombolysis, mechanical thrombectomy, pharmacomechanical thrombolysis, thrombus aspiration, or a combination of the above [4­8]. Pharmacological thrombolysis is defined as thrombus dissolution by selective catheter directed infusion of a thrombolytic agent. Case 9 Thrombolysis for acute lower limb ischaemia 81 Learning point Contraindications to percutaneous catheter-directed thrombolysis Absolute contraindications to percutaneous catheter-directed thrombolysis include cases presented with active or recent (within the past 10 days) internal or gastrointestinal bleeding that is not possible to treat, known intracranial tumour, neurosurgery or intracranial trauma within the past three months, a history of recent intracranial haemorrhage, abdominal surgery within the last three weeks, presence or development of compartment syndrome or limb ischaemia associated with tissue loss that may require urgent operation and/or irreversible nerve damage, and finally a known history of a cerebrovascular event within the previous six months including transient ischaemic attacks within the past two months. Relative contraindications include major non-vascular surgery or trauma during the past 10 days, a history of gastrointestinal bleeding, uncontrolled hypertension, puncture of non-compressible vessel, cardiopulmonary resuscitation within the last 10 days, recent eye operation, a history of severe contrast allergy, hepatic failure, especially in cases with coagulopathy, bacterial endocarditis, pregnancy or postpartum stage, diabetic haemorrhagic retinopathy, and life expectancy less than one year [5,7,14]. The patient was informed about both the benefits and the potential risks associated with the procedure and signed a written informed consent form. Under local anaesthesia the right-to-left femoral­femoral graft was single-wall punctured using ultrasound guidance and a 4Fr sheath was antegrade placed. A straight 4Fr catheter with multiple side-holes was carefully advanced just distal to the sheath tip. Both sheath and catheter were secured in place and thrombolysis through the catheter was initiated as per institutional protocol. The patient was then transferred to a high dependency unit where she was closely monitored for 24 hours (blood pressure measurement, heart rate, groin assessment). Expert comment Thrombolytic or fibrinolytic agents are extensively used for the treatment of ischaemia by enhancing the endogenous thrombolytic system. Streptokinase is no longer the preferred agent as it has been demonstrated to be less effective and more antigenic [15]. After initiation of the thrombolytic therapy patient must be kept under continuous surveillance in order to detect any adverse events. Twenty-four hours after initiation of thrombolysis infusion the patient was transfered back to the angiographic suite for a control angiogram. Digital subtraction angiography performed through the sheath demonstrated satisfactory flow of the right-to-left femoral­femoral graft and the left side femoral­popliteal graft with no significant underlying lesions. The patient regained full motion and sensory feeling in the previously ischaemic limb and the distal foot was significantly warmer than before the procedure. Case 9 Thrombolysis for acute lower limb ischaemia 83 Expert comment One of the main advantages of transcatheter thrombolysis is that any underlying lesion can be relatively safely treated. Treatment of such lesions is mandatory considering the superior vessel patency rates at two years when underlying lesions were identified and treated compared with those when this was not the case (79% vs 9. The treatment of choice in such cases should be primary stenting, if this is possible. The long term anticoagulation plan was to restart the warfarin that the patient was receiving because of chronic atrial fibrillation. No immediate complications were noted and the patient was discharged the following day with instructions to visit the graft surveillance clinic after one month. These three trials all showed comparable results for limb salvage between surgery and catheter-directed thrombolysis. Thrombolysis should be the firstline treatment option, especially as there is published evidence that whenever thrombolysis fails, thrombectomy and/or graft revision are associated with low success rates [16]. More specifically, the incidence of peripheral bleeding ranges from 1% to 25%, and the incidence of intracranial bleeding is between 0% and 2. Less common complications include distal vessel embolization, compartment syndrome, reperfusion syndrome, amputation, puncture site complications (pseudo-aneurysm), and contrastrelated complications (renal failure and allergy reactions). Finally, it must be remembered that rarely some thrombolytic agents such as streptokinase may be associated with major allergic reactions. In view of both the potential benefits and the associated risks of such procedures, only patients with salvageable limbs. Currently, a number of agents are used, and several administration techniques have been proposed including regional intra-arterial infusion, intra-thrombus infusion, intra-thrombus bolusing, stepwise infusion, continuous infusion, graded infusion, and forced periodic infusion (pulse-spray technique). Regional intra-arterial infusion may be performed with the catheter placed just proximal to the occlusion or with its tip embedded in its most proximal segment. The intra-thrombus technique is characterized by delivery of the lytic agent inside the occlusion. Intrathrombus bolusing refers to initial administration of concentrated fibrolytic agent in the thrombus. Stepwise infusion involves the initial delivery of the agent in the proximal segment of the thrombus followed by stepwise advancement of the catheter to the distal segment. Intra-thrombus high-dose bolus infusion of a thrombolytic agent, followed by continuous infusion of low doses, is believed to be a less demanding and highly effective technique [6]. The technical or clinical success (defined as symptom relief or decrease in the severity of any subsequent surgical intervention, including amputation) depends on the lytic agent and the technique used [3]. Currently, there is no clear evidence as to whether surgery or catheter-directed thrombolysis provides better immediate and long-term results. Randomized clinical trials suggest that catheter-directed thrombolytic treatment is superior to open surgery when dealing with acute occlusions (symptoms for less than 14 days) in bypass grafts and long-segment lesions with inadequate run-off. In contrast, surgery is superior for subacute or chronic lesions and for occlusions in native arteries. Another significant conclusion of these trials is that thrombolysis outcomes are superior in acute occlusion (symptomatic for less than 14 days) and when the thrombosis affects a bypass graft rather than native artery [12,18]. Before deciding whether thrombolysis should be performed in a specific patient it is important to take into account the presenting symptoms and previous medical history and to evaluate the potential benefits and risks of the planned procedure. All the potential contraindications must be considered, mainly because of the high risk of bleeding associated with the use of lytic agents. Pre-procedure evaluation includes high-quality non-invasive imaging and basic laboratory evaluation. Thrombus aspiration involves the use of a large-lumen catheter (usually 6­8Fr) connected to a 50­60ml syringe to forcibly aspirate the thrombus from the occluded region and restore blood flow [19,20]. Percutaneous mechanical thrombectomy involves the use of percutaneous thrombectomy devices to break up the thrombus and remove it. The main advantage of the method is that it can be used in cases where thrombolysis is not indicated. Percutaneous thrombectomy devices Case 9 Thrombolysis for acute lower limb ischaemia 85 are defined according to their mechanism of action including devices that break up the clot mechanically, hydrodynamic/rheolytic catheters, ultrasonic catheters, and combined devices [3]. Finally, pharmaco-mechanical thrombolysis is a combination of mechanical disruption and pharmacological thrombolysis. This results in an increased lytic effect and a reduction in the total time required for the procedure. Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis. Working Party on Thrombolysis in the Management of Limb Ischemia Party on Thrombolysis in the Management of Limb Ischemia. Endovascular techniques in the treatment of acute limb ischemia: thrombolytic agents, trials, and percutaneous mechanical thrombectomy techniques. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Shirish Prabhudesai Expert commentary Narayan Karunanithy Case history A 69-year-old male patient presented to the emergency department with shortness of breath and chest pain. His past medical history included hypertension for which he was on two anti-hypertensive agents. The chest radiograph revealed evidence of acute pulmonary oedema, and the echocardiogram showed significantly impaired left ventricular function with an estimated ejection fraction of 15­20%. He underwent percutaneous coronary intervention with placement of a bare metal stent and insertion of a cardiac resynchronization device. Despite management of his cardiac disease, he presented on multiple occasions with sudden-onset severe episodes of shortness of breath. If the angulation required to view the renal ostium in profile is not achieved, a significant lesion at this site may be missed or underestimated. Also, a highly angulated renal artery may require access from the brachial artery rather than the common femoral artery. Interventional radiology and endovascular procedures Clinical tip Renal artery stenosis can generallybe crossed with a C2 angulated catheter. For severely angulated and downward-pointing renal arteries, an Sos Omni catheter is used to guide the wire into the distal renal artery. Alternatively, left brachial artery access allows an in-line approach to the renal artery. Expert comment the distal renal arteries are extremely prone to vasospasm and dissection. Hence, once the ostial lesion is crossed, the hydrophilic guidewire is exchanged for a 0. At this stage careful attention to technique to prevent even minimal wire movement and further administration of vasodilators can minimize the incidence of dissection and vasospasm. Fibromuscular dysplasia is a disease of unknown aetiology, predominantly found in young to middle-aged women (15­50 years), and usually affects the distal two-thirds of the renal arteries. Hypertension and renal dysfunction are initially treated medically with renal artery stenting, which superseded balloon angioplasty [11], and has largely replaced surgical re-vascularization which is reserved for refractory cases [12]. However, given the potential complications of renal artery stenting [13], investigators have sought better evidence for its efficacy and safety.

References

• Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003; 289:2685-2694.
• Zahradnik JM. Adenovirus pneumonia. Semin Respir Infect 1987;2(2):104-11.
• Halanych JH, Shuaib F, Parmar G, et al. Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Epidemiol 2011;173:1319-26.
• National Institutes of Health. ClinicalTrials.gov: Radiation therapy in treating patients who have undergone surgery for soft tissue sarcoma of the arms, hands, legs, or feet. http://clinicaltrials.gov/ct2/show/NCT00423618.
• Carabello BA, Usher BW, Hendrix GH, et al. Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick. J Am Coll Cardiol 1987;10(5):991-997.